🔎 Trials Near Me

Akèy › Skleroz Miltip › Ohio › Columbus

Etid klinik pou Skleroz Miltip nan Columbus, OH

7 etid pou Skleroz Miltip ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

Ap rekriteFaz 2
  • Local Institution - Site 104, Columbus
Laj 18 a 70 · Tout sèks · Mizajou Sep 25, 2026 · NCT07840326

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Ap rekriteEtid obsèvasyon
  • TG Therapeutics Investigational Trial Site, Columbus
  • TG Therapeutics Investigational Trial Site, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Ap rekriteFaz 2
  • The Ohio State University, Department of Psychiatry, Columbus
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Ap rekriteFaz 3
  • The Ohio State University- Site Number : 8400009, Columbus
  • The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Ap rekriteFaz 2
  • Riverside Methodist Hospital, Columbus
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06782490

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

Ap rekriteFaz 1
  • TG Therapeutics Investigational Trial Site, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037

Etid Skleroz Miltip nan lòt vil

Lòt etid nan Columbus

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.